Clinical Research Directory
Browse clinical research sites, groups, and studies.
To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Sponsor: Hyundai Pharm
Summary
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose-finding, Phase 2 Study to Assess the Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Official title: A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose-finding, Phase 2 Study to Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Key Details
Gender
All
Age Range
19 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2024-12-12
Completion Date
2026-12-31
Last Updated
2024-12-13
Healthy Volunteers
No
Conditions
Interventions
HD-6277 100mg
PO, QD
HD-6277 50mg
PO, QD
HD-6277 25mg
PO, QD
Placebo
PO, QD
Locations (1)
Korea University Anam Hospital
Seoul, South Korea